SYNLAB UK & Ireland:

Chris Cook

Click here to return to the Management page

Chris Cook

Chief Information Officer

Chris joined SYNLAB UK and Ireland in May 2020 to take on responsibility for information technology support, development and strategy.  He also holds the role of senior information risk officer (SIRO).

Chris worked in IT at British Airways for 10 years and has subsequently held a number of chief information officer (CIO) and IT director roles in organisations such as Nuffield Health and Alliance Medical before taking on an interim CIO role for Bolton NHS Foundation Trust. Outside the healthcare sector he was CIO for P&O Ferries where he led an ecommerce transformation programme; he also held interim CIO roles at Manchester Airports Group and the Royal Society of Chemistry before returning to the healthcare sector with SYNLAB.  He has a BA in Mathematics from the University of York and an MSc in Information Technology from the University of Warwick.

Latest SYNLAB UK & Ireland News
Press Statement: SYNLAB UK & Ireland Announced As Partner In Major Pathology Partnership Contract

6th October 2020 We are delighted to announce that SYNLAB UK & Ireland will become the new pathology partner to Guy’s and St Thomas’ NHS…

Read More (about 'Press Statement: SYNLAB UK & Ireland Announced As Partner In Major Pathology Partnership Contract')
Supporting UEFA to Restore European Football Competitions and Matches in a Safe Environment.

Delivering COVID-19 Testing Across All UEFA Competitions We are proud to be supporting UEFA, governing body of European football, with COVID-19 testing across all UEFA…

Read More (about 'Supporting UEFA to Restore European Football Competitions and Matches in a Safe Environment.')
SYNLAB Announce Agreement with Arquer Diagnostics for Bladder Cancer Testing

13 July 2020 SYNLAB UK & Ireland and Arquer Diagnostics, a UK-based company committed to manufacturing and marketing innovative, non-invasive tests for diagnosing and monitoring…

Read More (about 'SYNLAB Announce Agreement with Arquer Diagnostics for Bladder Cancer Testing')
GENDER Pay Gap Report 2019-20

April 2020 Introduction Following the introduction of the Gender Pay Gap (‘GPG’) Transparency Regulations in 2017, SYNLAB UK & Ireland is pleased to provide their…

Read More (about 'GENDER Pay Gap Report 2019-20')
Modern Slavery & Human Trafficking Statement 2020

January 2020 This is the SYNLAB Group’s Modern Slavery and Human Trafficking Statement under Section 54 of the UK Modern Slavery Act 2015 (MSA) for…

Read More (about 'Modern Slavery & Human Trafficking Statement 2020')
SYNLAB and Scopio Bring 24/7 Veterinary Digital Cytology to the UK

13th May 2020 SYNLAB UK & Ireland’s Veterinary Pathology Group (VPG) and Scopio Labs, an advanced digital microscopy company, today announced that they have signed…

Read More (about 'SYNLAB and Scopio Bring 24/7 Veterinary Digital Cytology to the UK')
SYNLAB Laboratory Services Maintains ISO 15189:2012 UKAS Accreditation

7th April 2020 – SYNLAB Laboratory Services, part of Europe’s leading medical diagnostics provider SYNLAB Group, is pleased to announce that the company has successfully…

Read More (about 'SYNLAB Laboratory Services Maintains ISO 15189:2012 UKAS Accreditation')
SYNLAB Laboratory Services Maintains UKAS Accreditation

3rd April 2020 – SYNLAB Laboratory Services, a specialist workplace drug and alcohol testing laboratory, today announced that the company has successfully maintained its United…

Read More (about 'SYNLAB Laboratory Services Maintains UKAS Accreditation')
Press Statement: SYNLAB UK & Ireland Confirmed as Preferred NHS Strategic Partner

21 January 2020 SYNLAB UK & Ireland has been confirmed as the preferred strategic partner to transform and deliver NHS pathology services in South East London. SYNLAB…

Read More (about 'Press Statement: SYNLAB UK & Ireland Confirmed as Preferred NHS Strategic Partner')
Update On Submitting Samples Where Mycobacterial Disease Is Suspected

20 January 2020 Please note that in order to comply with the health and safety regulations surrounding the handling and potential culture of samples containing…

Read More (about 'Update On Submitting Samples Where Mycobacterial Disease Is Suspected')